Melina G. Verso

Perugia, 06123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Cancer-Associated Thrombosis in Patients Treated with Immune Checkpoint Inhibitors.

Cancer-Associated Thrombosis in Patients Treated with Immune Checkpoint Inhibitors.

Journal: International journal of molecular sciences

Published: January 07, 2026

Response to Comment on: "Targeted anti-cancer agents and risk of venous thromboembolism".

Response to Comment on: "Targeted anti-cancer agents and risk of venous thromboembolism".

Journal: Haematologica

Published: April 09, 2025

Targeted anti-cancer agents and risk of venous thromboembolism.

Targeted anti-cancer agents and risk of venous thromboembolism.

Journal: Haematologica

Published: November 19, 2024

Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience.

Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience.

Journal: Internal and emergency medicine

Published: February 25, 2024

Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study.

Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study.

Journal: Thrombosis research

Published: January 13, 2024

Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive.

Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive.

Journal: Internal and emergency medicine

Published: March 11, 2023

Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents.

Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents.

Journal: Seminars in oncology

Published: September 05, 2022

Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.

Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.

Journal: Thrombosis and haemostasis

Published: April 05, 2022

Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study.

Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 24, 2021

Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding.

Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding.

Journal: Thrombosis research

Published: June 16, 2021

Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism.

Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 11, 2021

Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism.

Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism.

Journal: Trends in cardiovascular medicine

Published: December 04, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026